Clinical Trial Detail

NCT ID NCT02087241
Title Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Adavosertib

Carboplatin + Pemetrexed Disodium

Age Groups: adult

No variant requirements are available.